explore -WSS

explore

author：leisure time 2025-10-02 22:28:30 - browse：56842

In a lab at Harvard Medical School, Professor David A. Sinclair looks into the camera from behind a row of bottles — coverage from STAT — David Sinclair in his lab at Harvard Medical School. Craig F. Walker/Globe Staff

Renowned Harvard University geneticist and longevity researcher David Sinclair recently made an astonishing assertion: Scientists had developed the first pill — well, a soft, beef-flavored chew — “proven to reverse aging” in dogs. Which miracle molecules delivered this supposed scientific breakthrough, he didn’t say. But he told his 438,000 followers on X where they could buy it: the website of Animal Bioscience, a veterinary supplement company he founded and which is headed by his brother, Nick Sinclair.

The claim in a company news release, followed by the tweet stating that the supplement was “proven to slow the effects of aging,” has sparked outrage from other scientists online, and the board of an international organization of top longevity researchers — which David Sinclair leads — will discuss the matter at its meeting this week.

Despite his enthusiasm, there is no published scientific research that has yet demonstrated the compounds in Animal Bioscience’s supplements — which have been on the market for more than a year — reverse or even slow aging in dogs.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Cancer drug shortages should be causing more outrage
Next article： Pharma patents targeted by Biden in move to slash drug prices

hotspot

WSS

The woman behind the Dana Farber

Boeing's 1st astronaut flight bumped into next year, more repairs needed

FDA needs staff influx to meet gene therapy needs, Marks says

NYC plans to house migrants on an island in the East River

What PEPFAR has meant on the ground in Ukraine

Roche to buy Carmot Therapeutics, developer of obesity drugs

knowledge

explore

knowledge

Anesthesiologist group: stop taking Ozempic before surgery

Israel demolishes home of alleged Palestinian attacker, fueling West Bank tensions

BioMarin wins approval for gene therapy to treat hemophilia A

Leukemia patients are helped by Syndax's new type of therapy

Medical records are filled with copy

In medicine, common shorthands can shortchange care

Wildfire smoke exposes gaps in outdoor worker protections

Supreme Court wrestles with OxyContin maker's bankruptcy deal

Dobbs anniversary: the lost opportunity of abortion as health care

Prince Harry and Meghan to work on film adaptation of 'Meet Me at the Lake' novel

explore

'The Exorcist' director William Friedkin dead at 87

FDA approves world's first CRISPR

CMS should re

At least 12 people were injured in a blast at a port in northwest Turkey

Judges halt a Biden rule offering student debt relief for those alleging colleges misled them

FDA needs staff influx to meet gene therapy needs, Marks says

knowledge

knowledge

hotspot

entertainment